Skip to main content
JS Link, Inc. logo

JS Link, Inc. — Investor Relations & Filings

Ticker · 127120 ISIN · KR7127120004 KO Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 127120

About JS Link, Inc.

https://en.jslink.co.kr/

JS Link, Inc. is a company with dual operations in biotechnology and advanced materials manufacturing. Formerly known as DNA Link, Inc., its biotechnology division is a genome-based research and development firm. It specializes in genomic mass analysis technology, providing sequencing and analysis services for DNA, RNA, and other genomic data to advance personalized medicine. The company also operates a division dedicated to the manufacturing of high-performance sintered permanent magnets, which are produced using rare earth materials.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” (Quarterly Report) covering the period January 1 to March 31, 2026, filed with the Financial Supervisory Service and Korea Exchange. It includes detailed sections on company overview, subsidiary schedule, capital changes, shareholder structure, corporate history, statutory updates, business description, and prospective plans, consistent with a comprehensive interim/quarterly report rather than a brief earnings release or an announcement. Therefore, it meets the criteria for an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 80% confidence The document is a corporate disclosure of a single sales and supply contract award by JS Link, detailing contract parties, amounts, term, and conditions. It does not present a financial report (annual, quarterly, audit) or any board change, financing, share issuance, dividend, or other specialized filing. It is a routine regulatory announcement of a contract, best classified under the fallback category Regulatory Filings (RNS).
2026-05-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 95% confidence The document is a detailed Major Report (“주요사항보고서”) filed under Korean exchange rules, outlining the full terms of a new issuance of convertible bonds (amount, interest, conversion price formulas, call/put options, use of proceeds, investor details, etc.). This is not just a brief notice or “report publication announcement,” nor is it an annual, interim, or audit report. It concerns a financing activity—specifically, the company’s decision to issue convertible debt—so it falls squarely under the “Capital/Financing Update” category (CAP).
2026-05-13 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 86% confidence The document is a Korean "주요사항보고서" (Major Event Report) filed with the Financial Supervisory Service/Korea Exchange, announcing and detailing the decision to issue convertible bonds (amount, interest, conversion terms, put/call options and use of proceeds). This is a substantive financing disclosure, fitting the “Capital/Financing Update” category rather than a simple announcement or regulatory fallback.
2026-05-13 Korean
[기재정정]타법인주식및출자증권취득결정
Regulatory Filings
2026-05-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is an official ‘임원ㆍ주요주주 특정증권등 소유상황보고서’, which in English is a report of executives’ and major shareholders’ holdings and changes in specific securities. This clearly matches the description of insider trading or personal share transactions by company directors/executives. Hence it falls under the Director’s Dealing category (DIRS).
2026-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.